Loading clinical trials...
Loading clinical trials...
An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80 mg+ Amlodipine 5 mg Fixed-dose Combination vs. Telmisartan 80 mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg Monotherapy
Conditions
Interventions
Telmisartan and amlodipine
Telmisartan
Locations
4
Japan
1235.36.01 Boehringer Ingelheim Investigational Site
Chuo-ku,Tokyo, Japan
1235.36.04 Boehringer Ingelheim Investigational Site
Hiroshima, Hiroshima, Japan
1235.36.02 Boehringer Ingelheim Investigational Site
Shinjuku-ku, Tokyo, Japan
1235.36.03 Boehringer Ingelheim Investigational Site
Suita, Osaka, Japan
Start Date
October 1, 2010
Primary Completion Date
June 1, 2011
Last Updated
June 27, 2014
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions